Healthcare, ranked by moat.
728 Healthcare companies are scored nightly from primary SEC filings, each 0–100 on Business Trend, Pricing Power, Returns on Capital, Balance-Sheet Safety, and Capital Allocation, via the public methodology. Cross-sector views: the Top 100, the Screener, and the A–Z directory.
- Companies scored
- 728
- Median Moat Score
- 46
- Wide moats
- 27
- Quality on sale
- 5
The Index API serves each sector’s 500 widest moats, so the 228 lowest-scored Healthcare names aren’t listed below yet. The stats above are computed over the 500 listed companies, except the scored count, which is the full sector.
Widest moats in Healthcare
Quality on sale in Healthcare
- EMBECTA CORP. 86% below value if growth stopped today
- SIGA Technologies, Inc. 66% below value if growth stopped today
- SBC Medical Group Holdings Incorporated 41% below value if growth stopped today
- INNOVIVA, INC. 36% below value if growth stopped today
- UTAH MEDICAL PRODUCTS INC 11% below value if growth stopped today
The 500 widest Healthcare moats
| Watchlist | # | Company | Ticker | Mkt cap | Moat Score | Moat | |
|---|---|---|---|---|---|---|---|
| 1 | IDEXX LABORATORIES INC /DE | IDXX | $43.4B | 96 | Wide moat | 362% above value if growth stopped today | |
| 2 | ELI LILLY & Co | LLY | $1.13T | 94 | Wide moat | 1526% above value if growth stopped today | |
| 3 | GARMIN LTD | GRMN | $46.8B | 94 | Wide moat | 227% above value if growth stopped today | |
| 4 | CORCEPT THERAPEUTICS INC | CORT | $10.1B | 92 | Wide moat | 750% above value if growth stopped today | |
| 5 | ResMed Inc. | RMD | $28.6B | 92 | Wide moat | 173% above value if growth stopped today | |
| 6 | IRADIMED CORPORATION | IRMD | $1.2B | 91 | Wide moat | 532% above value if growth stopped today | |
| 7 | Intuitive Surgical, Inc. | ISRG | $119.8B | 90 | Wide moat | 500% above value if growth stopped today | |
| 8 | Merck & Co., Inc. | MRK | $324.1B | 89 | Wide moat | 101% above value if growth stopped today | |
| 9 | Zoetis Inc. | ZTS | $32.0B | 89 | Wide moat | 23% above value if growth stopped today | |
| 10 | ALIGN TECHNOLOGY, INC. | ALGN | $11.9B | 88 | Wide moat | 138% above value if growth stopped today | |
| 11 | EXELIXIS, INC. | EXEL | $14.5B | 87 | Wide moat | 466% above value if growth stopped today | |
| 12 | UNITED THERAPEUTICS Corp | UTHR | $23.1B | 86 | Wide moat | 111% above value if growth stopped today | |
| 13 | BADGER METER, INC. | BMI | $4.7B | 85 | Wide moat | 323% above value if growth stopped today | |
| 14 | MIMEDX GROUP, INC. | MDXG | $622M | 84 | Wide moat | 32% above value if growth stopped today | |
| 15 | Electromed, Inc. | ELMD | $321M | 83 | Wide moat | 812% above value if growth stopped today | |
| 16 | SBC Medical Group Holdings Incorporated | SBC | $314M | 83 | Wide moat | 41% below value if growth stopped today | |
| 17 | PACIFIC HEALTH CARE ORGANIZATION, INC. | PFHO | $10.6M | 83 | Wide moat | 5% above value if growth stopped today | |
| 18 | INNOVIVA, INC. | INVA | $1.6B | 82 | Wide moat | 36% below value if growth stopped today | |
| 19 | HARMONY BIOSCIENCES HOLDINGS, INC. | HRMY | $2.0B | 82 | Wide moat | 9% above value if growth stopped today | |
| 20 | Mettler-Toledo International Inc. | MTD | $27.0B | 82 | Wide moat | 182% above value if growth stopped today | |
| 21 | Lifevantage Corp | LFVN | $81.2M | 82 | Wide moat | 51% above value if growth stopped today | |
| 22 | CATALYST PHARMACEUTICALS, INC. | CPRX | $3.9B | 82 | Wide moat | 234% above value if growth stopped today | |
| 23 | REGENERON PHARMACEUTICALS, INC. | REGN | Not reported | 81 | Wide moat | No price data | |
| 24 | AGILENT TECHNOLOGIES, INC. | A | $39.2B | 81 | Wide moat | 174% above value if growth stopped today | |
| 25 | VERTEX PHARMACEUTICALS INC / MA | VRTX | $121.2B | 81 | Wide moat | 228% above value if growth stopped today | |
| 26 | biote Corp. | BTMD | Not reported | 80 | Wide moat | No price data | |
| 27 | Waters Corporation | WAT | $22.3B | 80 | Wide moat | 190% above value if growth stopped today | |
| 28 | OPTEX SYSTEMS HOLDINGS, INC. | OPXS | $76.8M | 80 | Narrow moat | 206% above value if growth stopped today | |
| 29 | DEXCOM, INC. | DXCM | $27.5B | 78 | Narrow moat | 358% above value if growth stopped today | |
| 30 | GLOBUS MEDICAL, INC. | GMED | Not reported | 78 | Narrow moat | No price data | |
| 31 | LEMAITRE VASCULAR, INC. | LMAT | $2.2B | 78 | Narrow moat | 492% above value if growth stopped today | |
| 32 | Viemed Healthcare, Inc. | VMD | $447M | 78 | Narrow moat | 293% above value if growth stopped today | |
| 33 | TRANE TECHNOLOGIES PLC | TT | Not reported | 78 | Narrow moat | No price data | |
| 34 | VERALTO CORPORATION | VLTO | $22.9B | 77 | Narrow moat | 128% above value if growth stopped today | |
| 35 | UTAH MEDICAL PRODUCTS INC | UTMD | $214M | 77 | Narrow moat | 11% below value if growth stopped today | |
| 36 | LONGDUODUO COMPANY LIMITED | LDDD | $15.3M | 76 | Narrow moat | No price data | |
| 37 | TERADYNE, INC. | TER | $54.6B | 76 | Narrow moat | 787% above value if growth stopped today | |
| 38 | AMETEK, Inc. | AME | $55.4B | 76 | Narrow moat | 229% above value if growth stopped today | |
| 39 | EDWARDS LIFESCIENCES CORPORATION | EW | $48.0B | 76 | Narrow moat | 187% above value if growth stopped today | |
| 40 | NATURES SUNSHINE PRODUCTS INC | NATR | $357M | 75 | Narrow moat | 96% above value if growth stopped today | |
| 41 | KEYSIGHT TECHNOLOGIES, INC. | KEYS | Not reported | 75 | Narrow moat | No price data | |
| 42 | Elite Pharmaceuticals, Inc. | ELTP | $420M | 75 | Narrow moat | 293% above value if growth stopped today | |
| 43 | WEST PHARMACEUTICAL SERVICES, INC. | WST | $23.6B | 75 | Narrow moat | 263% above value if growth stopped today | |
| 44 | MSA Safety Inc | MSA | $6.8B | 74 | Narrow moat | 232% above value if growth stopped today | |
| 45 | VYCOR MEDICAL, INC. | VYCO | $2.3M | 74 | Narrow moat | No price data | |
| 46 | SIGA Technologies, Inc. | SIGA | $223M | 73 | Narrow moat | 66% below value if growth stopped today | |
| 47 | LANTHEUS HOLDINGS, INC. | LNTH | $6.8B | 73 | Narrow moat | 161% above value if growth stopped today | |
| 48 | CHAMPIONS ONCOLOGY, INC. | CSBR | $84.5M | 73 | Narrow moat | 2000% above value if growth stopped today | |
| 49 | NEUROCRINE BIOSCIENCES, INC. | NBIX | $17.6B | 73 | Narrow moat | 534% above value if growth stopped today | |
| 50 | TACTILE SYSTEMS TECHNOLOGY INC | TCMD | $617M | 73 | Narrow moat | 160% above value if growth stopped today | |
| 51 | ENSIGN GROUP, INC | ENSG | $10.0B | 72 | Narrow moat | 302% above value if growth stopped today | |
| 52 | PRO-DEX, INC. | PDEX | $179M | 72 | Narrow moat | 161% above value if growth stopped today | |
| 53 | BillionToOne, Inc. | BLLN | $2.7B | 72 | Narrow moat | No price data | |
| 54 | GILEAD SCIENCES, INC. | GILD | $160.5B | 71 | Narrow moat | 88% above value if growth stopped today | |
| 55 | SANUWAVE Health, Inc. | SNWV | $50.9M | 71 | Narrow moat | No price data | |
| 56 | Indivior Pharmaceuticals, Inc. | INDV | $5.1B | 70 | Narrow moat | No price data | |
| 57 | EMBECTA CORP. | EMBC | $192M | 70 | Narrow moat | 86% below value if growth stopped today | |
| 58 | Vontier Corporation | VNT | $4.4B | 70 | Narrow moat | 3% below value if growth stopped today | |
| 59 | CHEMED CORPORATION | CHE | $7.0B | 69 | Narrow moat | 135% above value if growth stopped today | |
| 60 | ONTO INNOVATION INC. | ONTO | $13.5B | 69 | Narrow moat | 522% above value if growth stopped today | |
| 61 | NORTHROP GRUMMAN CORP /DE/ | NOC | $77.0B | 69 | Narrow moat | 65% above value if growth stopped today | |
| 62 | Illumina, Inc. | ILMN | $29.7B | 69 | Narrow moat | No price data | |
| 63 | Amgen Inc. | AMGN | $202.6B | 68 | Narrow moat | 102% above value if growth stopped today | |
| 64 | HALOZYME THERAPEUTICS, INC. | HALO | $9.6B | 68 | Narrow moat | 170% above value if growth stopped today | |
| 65 | ABBOTT LABORATORIES | ABT | $179.2B | 68 | Narrow moat | 91% above value if growth stopped today | |
| 66 | STRYKER CORP | SYK | Not reported | 68 | Narrow moat | No price data | |
| 67 | Cognex Corporation | CGNX | $10.4B | 68 | Narrow moat | 583% above value if growth stopped today | |
| 68 | Shoulder Innovations, Inc. | SI | $421M | 67 | Narrow moat | No price data | |
| 69 | CARLSMED, INC. | CARL | $287M | 67 | Narrow moat | No price data | |
| 70 | ZIMMER BIOMET HOLDINGS, INC. | ZBH | $17.9B | 67 | Narrow moat | 2% above value if growth stopped today | |
| 71 | BIOGEN INC. | BIIB | $29.7B | 67 | Narrow moat | 39% above value if growth stopped today | |
| 72 | Rockwell Automation, Inc. | ROK | $51.9B | 67 | Narrow moat | 347% above value if growth stopped today | |
| 73 | Privia Health Group, Inc. | PRVA | $3.2B | 67 | Narrow moat | 1872% above value if growth stopped today | |
| 74 | FITLIFE BRANDS, INC. | FTLF | $96.3M | 66 | Narrow moat | 60% above value if growth stopped today | |
| 75 | UNIVERSAL HEALTH SERVICES, INC. | UHS | $10.0B | 66 | Narrow moat | 9% below value if growth stopped today | |
| 76 | Medinotec Inc. | MDNC | Not reported | 65 | Narrow moat | No price data | |
| 77 | BOSTON SCIENTIFIC CORP | BSX | Not reported | 65 | Narrow moat | No price data | |
| 78 | BETA BIONICS, INC. | BBNX | $703M | 65 | Narrow moat | No price data | |
| 79 | Penumbra, Inc | PEN | $12.5B | 65 | Narrow moat | 6707% above value if growth stopped today | |
| 80 | Omada Health, Inc. | OMDA | $1.2B | 65 | Narrow moat | No price data | |
| 81 | STERIS plc | STE | $20.9B | 65 | Narrow moat | 223% above value if growth stopped today | |
| 82 | AUTOSCOPE TECHNOLOGIES CORP | AATC | $29.6M | 65 | Narrow moat | 13% above value if growth stopped today | |
| 83 | Gyre Therapeutics, Inc. | GYRE | $542M | 65 | Narrow moat | 1032% above value if growth stopped today | |
| 84 | Leonardo DRS, Inc. | DRS | $12.8B | 64 | Narrow moat | 425% above value if growth stopped today | |
| 85 | LIGAND PHARMACEUTICALS INC | LGND | $5.9B | 64 | Narrow moat | 528% above value if growth stopped today | |
| 86 | FUNCTIONAL BRANDS INC. | MEHA | $86041 | 64 | Narrow moat | 94% below value if growth stopped today | |
| 87 | Neuraxis, INC | NRXS | $72.4M | 64 | Narrow moat | No price data | |
| 88 | TELEDYNE TECHNOLOGIES INC | TDY | $30.3B | 64 | Narrow moat | 161% above value if growth stopped today | |
| 89 | CODA OCTOPUS GROUP, INC. | CODA | $113M | 64 | Narrow moat | 147% above value if growth stopped today | |
| 90 | TENET HEALTHCARE CORP | THC | $20.3B | 63 | Narrow moat | 9% above value if growth stopped today | |
| 91 | USANA HEALTH SCIENCES, INC. | USNA | $390M | 63 | Narrow moat | 45% below value if growth stopped today | |
| 92 | UFP Technologies, Inc. | UFPT | $1.8B | 63 | Narrow moat | 259% above value if growth stopped today | |
| 93 | HIMS & HERS HEALTH, INC. | HIMS | $7.3B | 63 | Narrow moat | No price data | |
| 94 | U S PHYSICAL THERAPY INC /NV | USPH | Not reported | 62 | Narrow moat | No price data | |
| 95 | ANI Pharmaceuticals, Inc. | ANIP | $1.7B | 62 | Narrow moat | 377% above value if growth stopped today | |
| 96 | SOLVENTUM CORPORATION | SOLV | $13.5B | 62 | Narrow moat | 26% below value if growth stopped today | |
| 97 | Krystal Biotech, Inc. | KRYS | $9.8B | 62 | Narrow moat | 7956% above value if growth stopped today | |
| 98 | Prestige Consumer Healthcare Inc. | PBH | $2.4B | 62 | Narrow moat | 7% below value if growth stopped today | |
| 99 | InfuSystem Holdings, Inc. | INFU | $184M | 62 | Narrow moat | 21% above value if growth stopped today | |
| 100 | DELCATH SYSTEMS, INC. | DCTH | $424M | 62 | Narrow moat | No price data | |
| 101 | NOVAVAX, INC. | NVAX | $1.2B | 62 | Narrow moat | No price data | |
| 102 | Niagen Bioscience, Inc. | NAGE | $256M | 62 | Narrow moat | No price data | |
| 103 | CADRE HOLDINGS, INC. | CDRE | $1.3B | 61 | Narrow moat | 150% above value if growth stopped today | |
| 104 | BIO ESSENCE CORP. | BIOE | $10.3M | 61 | Narrow moat | No price data | |
| 105 | IMAX Corporation | IMAX | $2.3B | 61 | Narrow moat | 167% above value if growth stopped today | |
| 106 | CeriBell, Inc. | CBLL | $634M | 61 | Narrow moat | No price data | |
| 107 | ACADIA PHARMACEUTICALS INC | ACAD | $4.2B | 61 | Narrow moat | No price data | |
| 108 | BIOVENTUS INC. | BVS | $813M | 61 | Narrow moat | 489% above value if growth stopped today | |
| 109 | NATIONAL HEALTHCARE CORP | NHC | $3.5B | 60 | Narrow moat | 171% above value if growth stopped today | |
| 110 | VERACYTE, INC. | VCYT | $4.5B | 60 | Narrow moat | No price data | |
| 111 | Kiniksa Pharmaceuticals International, plc | KNSA | $5.0B | 60 | Narrow moat | 2641% above value if growth stopped today | |
| 112 | PTC Therapeutics, Inc. | PTCT | $6.3B | 60 | Shallow moat | No price data | |
| 113 | Progyny, Inc. | PGNY | $2.6B | 60 | Shallow moat | 300% above value if growth stopped today | |
| 114 | Bristol-Myers Squibb Company | BMY | $126.4B | 60 | Shallow moat | 27% below value if growth stopped today | |
| 115 | RIGEL PHARMACEUTICALS INC | RIGL | $673M | 60 | Shallow moat | No price data | |
| 116 | Heartflow, Inc. | HTFL | $2.1B | 59 | Shallow moat | No price data | |
| 117 | AbbVie Inc. | ABBV | $458.5B | 59 | Shallow moat | 223% above value if growth stopped today | |
| 118 | VAXART, INC. | VXRT | $120M | 59 | Shallow moat | No price data | |
| 119 | ELECTROMEDICAL TECHNOLOGIES, INC. | EMED | $46329 | 59 | Shallow moat | No price data | |
| 120 | MANNATECH INC | MTEX | $8.6M | 58 | Shallow moat | No price data | |
| 121 | Amphastar Pharmaceuticals, Inc. | AMPH | $854M | 58 | Shallow moat | 36% below value if growth stopped today | |
| 122 | COLLEGIUM PHARMACEUTICAL, INC | COLL | $1.1B | 58 | Shallow moat | 49% below value if growth stopped today | |
| 123 | Immunocore Holdings plc | IMCR | $1.8B | 58 | Shallow moat | No price data | |
| 124 | National Vision Holdings, Inc. | EYE | $1.6B | 58 | Shallow moat | 238% above value if growth stopped today | |
| 125 | MERIT MEDICAL SYSTEMS INC | MMSI | $4.4B | 58 | Shallow moat | 165% above value if growth stopped today | |
| 126 | EVOFEM BIOSCIENCES, INC. | EVFM | $1M | 57 | Shallow moat | No price data | |
| 127 | Addus HomeCare Corp | ADUS | $2.1B | 57 | Shallow moat | 184% above value if growth stopped today | |
| 128 | TALKSPACE, INC. | TALK | $869M | 57 | Shallow moat | No price data | |
| 129 | BIO-TECHNE Corp | TECH | $11.1B | 57 | Shallow moat | 360% above value if growth stopped today | |
| 130 | Aurinia Pharmaceuticals Inc. | AUPH | $2.0B | 57 | Shallow moat | No price data | |
| 131 | INSULET CORPORATION | PODD | $11.5B | 57 | Shallow moat | 401% above value if growth stopped today | |
| 132 | MIND TECHNOLOGY, INC | MIND | $50.4M | 56 | Shallow moat | 373% above value if growth stopped today | |
| 133 | MOVADO GROUP, INC. | MOV | $826M | 56 | Shallow moat | 74% above value if growth stopped today | |
| 134 | Inspire Medical Systems, Inc. | INSP | $1.4B | 56 | Shallow moat | No price data | |
| 135 | KEROS THERAPEUTICS, INC. | KROS | $197M | 56 | Shallow moat | No price data | |
| 136 | Spero Therapeutics, Inc. | SPRO | $67.1M | 56 | Shallow moat | No price data | |
| 137 | THE PENNANT GROUP, INC. | PNTG | $1.4B | 56 | Shallow moat | 859% above value if growth stopped today | |
| 138 | 3M COMPANY | MMM | $91.5B | 56 | Shallow moat | 89% above value if growth stopped today | |
| 139 | NEPHROS, INC. | NEPH | $38.7M | 56 | Shallow moat | No price data | |
| 140 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | $2.7B | 55 | Shallow moat | 179% above value if growth stopped today | |
| 141 | ORGANOGENESIS HOLDINGS INC. | ORGO | $303M | 55 | Shallow moat | 76% above value if growth stopped today | |
| 142 | ADC Therapeutics SA | ADCT | $145M | 55 | Shallow moat | No price data | |
| 143 | BioMarin Pharmaceutical Inc | BMRN | $11.4B | 55 | Shallow moat | 486% above value if growth stopped today | |
| 144 | SkinHealth Systems Inc. | SKIN | $93.4M | 55 | Shallow moat | No price data | |
| 145 | Alpha Pro Tech, Ltd. | APT | $49.9M | 55 | Shallow moat | 14% above value if growth stopped today | |
| 146 | JRSIS HEALTH CARE CORPORATION | JRSS | $1.5M | 55 | Shallow moat | 85% below value if growth stopped today | |
| 147 | IRONWOOD PHARMACEUTICALS, INC. | IRWD | $605M | 55 | Shallow moat | 117% above value if growth stopped today | |
| 148 | BEONE MEDICINES LTD. | ONC | $469.6B | 54 | Shallow moat | No price data | |
| 149 | TRIMBLE INC. | TRMB | $12.5B | 54 | Shallow moat | 94% above value if growth stopped today | |
| 150 | ROPER TECHNOLOGIES INC | ROP | $39.2B | 54 | Shallow moat | 129% above value if growth stopped today | |
| 151 | THERMO FISHER SCIENTIFIC INC. | TMO | $211.1B | 54 | Shallow moat | 139% above value if growth stopped today | |
| 152 | TriSalus Life Sciences, Inc. | TLSI | $211M | 54 | Shallow moat | No price data | |
| 153 | MESA LABORATORIES, INC. | MLAB | $539M | 54 | Shallow moat | 115% above value if growth stopped today | |
| 154 | HEALTHCARE SERVICES GROUP, INC. | HCSG | $1.6B | 54 | Shallow moat | 198% above value if growth stopped today | |
| 155 | Itron, Inc. | ITRI | $3.8B | 54 | Shallow moat | 171% above value if growth stopped today | |
| 156 | OWLET, INC. | OWLT | $141M | 53 | Shallow moat | No price data | |
| 157 | LifeStance Health Group, Inc. | LFST | $4.2B | 53 | Shallow moat | No price data | |
| 158 | Fortive Corp | FTV | $19.5B | 53 | Shallow moat | 56% above value if growth stopped today | |
| 159 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | TEVA | $35.4B | 53 | Shallow moat | 4589% above value if growth stopped today | |
| 160 | ZIVO BIOSCIENCE, INC. | ZIVO | $18.1M | 53 | Shallow moat | No price data | |
| 161 | BIOCRYST PHARMACEUTICALS, INC. | BCRX | $2.0B | 53 | Shallow moat | No price data | |
| 162 | INTERPACE BIOSCIENCES, INC. | IDXG | $6.5M | 53 | Shallow moat | 77% below value if growth stopped today | |
| 163 | TransMedics Group, Inc. | TMDX | $2.5B | 53 | Shallow moat | No price data | |
| 164 | Alkermes plc. | ALKS | $8.8B | 52 | Shallow moat | 226% above value if growth stopped today | |
| 165 | MYOMO, INC. | MYO | $37.3M | 52 | Shallow moat | No price data | |
| 166 | BIOTRICITY INC. | BTCY | $3.3M | 52 | Shallow moat | No price data | |
| 167 | HAEMONETICS CORPORATION | HAE | $3.6B | 52 | Shallow moat | 82% above value if growth stopped today | |
| 168 | Quest Diagnostics Inc | DGX | $25.0B | 52 | Shallow moat | 130% above value if growth stopped today | |
| 169 | VERICEL CORPORATION | VCEL | $2.3B | 52 | Shallow moat | No price data | |
| 170 | PROTALIX BIOTHERAPEUTICS, INC. | PLX | $191M | 52 | Shallow moat | No price data | |
| 171 | Lite Strategy, Inc. | LITS | $6.6M | 52 | Shallow moat | No price data | |
| 172 | Warby Parker Inc. | WRBY | $3.1B | 52 | Shallow moat | No price data | |
| 173 | PHATHOM PHARMACEUTICALS, INC. | PHAT | $817M | 52 | Shallow moat | No price data | |
| 174 | X4 Pharmaceuticals, Inc. | XFOR | $350M | 51 | Shallow moat | No price data | |
| 175 | BRUKER CORPORATION | BRKR | $9.2B | 51 | Shallow moat | 199% above value if growth stopped today | |
| 176 | DANAHER CORPORATION | DHR | $135.4B | 51 | Shallow moat | 120% above value if growth stopped today | |
| 177 | TG THERAPEUTICS, INC. | TGTX | $8.7B | 51 | Shallow moat | 5980% above value if growth stopped today | |
| 178 | BIORESTORATIVE THERAPIES, INC. | BRTX | $2.6M | 51 | Shallow moat | No price data | |
| 179 | Orchestra BioMed Holdings, Inc. | OBIO | $213M | 51 | Shallow moat | No price data | |
| 180 | AKEBIA THERAPEUTICS, INC. | AKBA | $324M | 51 | Shallow moat | No price data | |
| 181 | NUTRA PHARMA CORP. | NPHC | $2.1M | 51 | Shallow moat | No price data | |
| 182 | Medtronic plc | MDT | $106.5B | 51 | Shallow moat | 69% above value if growth stopped today | |
| 183 | Profound Medical Corp. | PROF | $263M | 51 | Shallow moat | No price data | |
| 184 | InTest Corporation | INTT | $172M | 51 | Shallow moat | 64% above value if growth stopped today | |
| 185 | PUMA BIOTECHNOLOGY, INC. | PBYI | $402M | 51 | Shallow moat | 10% above value if growth stopped today | |
| 186 | REPLIGEN CORP | RGEN | $7.4B | 50 | Shallow moat | 542% above value if growth stopped today | |
| 187 | BioCorRx Inc. | BICX | $7.3M | 50 | Shallow moat | No price data | |
| 188 | CAPFORCE INC. | CFOR | $183M | 50 | Shallow moat | No price data | |
| 189 | Xtant Medical Holdings, Inc. | XTNT | $60M | 50 | Shallow moat | No price data | |
| 190 | CUMBERLAND PHARMACEUTICALS INC | CPIX | $98.9M | 50 | Shallow moat | No price data | |
| 191 | Sotera Health Co | SHC | Not reported | 50 | Shallow moat | No price data | |
| 192 | GE HEALTHCARE TECHNOLOGIES INC. | GEHC | Not reported | 50 | Shallow moat | No price data | |
| 193 | Electro-Sensors, Inc. | ELSE | $26.9M | 50 | Shallow moat | 633% above value if growth stopped today | |
| 194 | Mirion Technologies, Inc. | MIR | Not reported | 50 | Shallow moat | No price data | |
| 195 | Kewaunee Scientific Corporation | KEQU | $103M | 49 | Shallow moat | 22% below value if growth stopped today | |
| 196 | BridgeBio Pharma, Inc. | BBIO | $16.4B | 49 | Shallow moat | No price data | |
| 197 | SI-BONE, INC. | SIBN | $725M | 49 | Shallow moat | No price data | |
| 198 | ZAI LAB LIMITED | ZLAB | $21.3B | 49 | Shallow moat | No price data | |
| 199 | Allurion Technologies, Inc. | ALUR | $57.9M | 49 | Shallow moat | No price data | |
| 200 | YUBO INTERNATIONAL BIOTECH LIMITED | YBGJ | $2.4M | 49 | Shallow moat | No price data | |
| 201 | SELLAS Life Sciences Group, Inc. | SLS | $1.7B | 49 | Shallow moat | No price data | |
| 202 | RenovoRx, Inc. | RNXT | $31.7M | 49 | Shallow moat | No price data | |
| 203 | LivaNova PLC | LIVN | $4.3B | 49 | Shallow moat | No price data | |
| 204 | KORU MEDICAL SYSTEMS, INC. | KRMD | $178M | 49 | Shallow moat | No price data | |
| 205 | Aquestive Therapeutics, Inc. | AQST | $449M | 49 | Shallow moat | No price data | |
| 206 | Sarepta Therapeutics, Inc. | SRPT | $1.6B | 49 | Shallow moat | No price data | |
| 207 | Ultragenyx Pharmaceutical Inc. | RARE | $2.6B | 49 | Shallow moat | No price data | |
| 208 | VSee Health, Inc. | VSEE | $2.6M | 49 | Shallow moat | No price data | |
| 209 | Amylyx Pharmaceuticals, Inc. | AMLX | $2.0B | 49 | Shallow moat | No price data | |
| 210 | L3HARRIS TECHNOLOGIES, INC. | LHX | $56.1B | 49 | Shallow moat | 112% above value if growth stopped today | |
| 211 | Lexicon Pharmaceuticals, Inc. | LXRX | $838M | 49 | Shallow moat | No price data | |
| 212 | AYTU BIOPHARMA, INC | AYTU | $19.4M | 49 | Shallow moat | No price data | |
| 213 | CASTLE BIOSCIENCES, INC. | CSTL | $733M | 49 | Shallow moat | No price data | |
| 214 | MiniMed Group, Inc. | MMED | $4.7B | 49 | Shallow moat | No price data | |
| 215 | SIGHT SCIENCES, INC. | SGHT | $263M | 48 | Shallow moat | No price data | |
| 216 | ADMA BIOLOGICS, INC. | ADMA | $2.0B | 48 | Shallow moat | No price data | |
| 217 | Schrodinger, Inc. | SDGR | Not reported | 48 | Shallow moat | No price data | |
| 218 | DAVITA INC. | DVA | $16.1B | 48 | Shallow moat | 65% above value if growth stopped today | |
| 219 | CVRx, Inc. | CVRX | $125M | 48 | Shallow moat | No price data | |
| 220 | The Cooper Companies, Inc. | COO | $13.8B | 48 | Shallow moat | 216% above value if growth stopped today | |
| 221 | PULMONX CORPORATION | LUNG | $48.8M | 48 | Shallow moat | No price data | |
| 222 | AtriCure, Inc. | ATRC | $1.7B | 48 | Shallow moat | No price data | |
| 223 | INTELLIA THERAPEUTICS, INC. | NTLA | $1.2B | 48 | Shallow moat | No price data | |
| 224 | Bausch Health Companies Inc. | BHC | $1.6B | 47 | Shallow moat | 83% below value if growth stopped today | |
| 225 | ENVISTA HOLDINGS CORPORATION | NVST | $4.3B | 47 | Shallow moat | 230% above value if growth stopped today | |
| 226 | COMMUNITY HEALTH SYSTEMS, INC. | CYH | $378M | 47 | Shallow moat | 79% below value if growth stopped today | |
| 227 | Dare Bioscience, Inc. | DARE | $18.6M | 47 | Shallow moat | No price data | |
| 228 | ORTHOFIX MEDICAL INC. | OFIX | $448M | 47 | Shallow moat | No price data | |
| 229 | Elicio Therapeutics, Inc. | ELTX | $53.4M | 47 | Shallow moat | No price data | |
| 230 | Q32 Bio Inc. | QTTB | $195M | 47 | Shallow moat | No price data | |
| 231 | PMGC HOLDINGS INC. | ELAB | $72629 | 47 | Shallow moat | No price data | |
| 232 | QHSLab, Inc. | USAQ | $4.5M | 47 | Shallow moat | No price data | |
| 233 | Alphatec Holdings, Inc. | ATEC | $1.2B | 47 | Shallow moat | No price data | |
| 234 | LFTD PARTNERS INC. | LIFD | $3M | 47 | Shallow moat | 88% below value if growth stopped today | |
| 235 | Femasys Inc. | FEMY | $221M | 47 | Shallow moat | No price data | |
| 236 | IMMUNITYBIO, INC. | IBRX | $7.2B | 47 | Shallow moat | No price data | |
| 237 | Zevra Therapeutics, Inc. | ZVRA | $542M | 47 | Shallow moat | No price data | |
| 238 | electroCore, Inc. | ECOR | $49.5M | 47 | Shallow moat | No price data | |
| 239 | Zomedica Corp. | ZOMDF | Not reported | 47 | Shallow moat | No price data | |
| 240 | Bio-Rad Laboratories, Inc. | BIO | $8.6B | 47 | Shallow moat | No price data | |
| 241 | VASO CORPORATION | VASO | $33.4M | 47 | Shallow moat | 37% below value if growth stopped today | |
| 242 | QT IMAGING HOLDINGS, INC. | QTI | $33M | 47 | Shallow moat | No price data | |
| 243 | AMNEAL PHARMACEUTICALS, INC. | AMRX | Not reported | 47 | Shallow moat | No price data | |
| 244 | Agios Pharmaceuticals, Inc. | AGIO | $2.1B | 46 | Shallow moat | No price data | |
| 245 | Whitehawk Therapeutics, Inc. | WHWK | $175M | 46 | Shallow moat | No price data | |
| 246 | NEUTRA CORP. | NTRR | $274358 | 46 | Shallow moat | No price data | |
| 247 | 908 DEVICES INC. | MASS | $259M | 46 | Shallow moat | No price data | |
| 248 | Innovative Eyewear, Inc. | LUCY | $3.6M | 46 | Shallow moat | No price data | |
| 249 | EARTH SCIENCE TECH, INC. | ETST | $35M | 46 | Shallow moat | Around the value if growth stopped today | |
| 250 | RHYTHM PHARMACEUTICALS, INC. | RYTM | $6.9B | 46 | Shallow moat | No price data | |
| 251 | Phibro Animal Health Corporation | PAHC | Not reported | 46 | Shallow moat | No price data | |
| 252 | COHERENT CORP. | COHR | $44.0B | 46 | Shallow moat | 840% above value if growth stopped today | |
| 253 | LEXARIA BIOSCIENCE CORP. | LEXX | $10.9M | 46 | Shallow moat | No price data | |
| 254 | CYTEK BIOSCIENCES, INC. | CTKB | $573M | 46 | Shallow moat | No price data | |
| 255 | Cardiff Lexington Corporation | CDIX | $9.6M | 46 | Shallow moat | No price data | |
| 256 | Anika Therapeutics, Inc. | ANIK | $208M | 46 | Shallow moat | No price data | |
| 257 | Verrica Pharmaceuticals Inc. | VRCA | $86.2M | 46 | Shallow moat | No price data | |
| 258 | SANARA MEDTECH INC. | SMTI | $229M | 45 | Shallow moat | No price data | |
| 259 | ADIA NUTRITION, INC. | ADIA | $15.1M | 45 | Shallow moat | No price data | |
| 260 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | $36.0B | 45 | Shallow moat | No price data | |
| 261 | LogicMark, Inc. | LGMK | $552696 | 45 | Shallow moat | No price data | |
| 262 | TRULIEVE CANNABIS CORP. | TRLV | $1.6B | 45 | Shallow moat | No price data | |
| 263 | BULLFROG AI HOLDINGS, INC. | BFRG | $6.7M | 45 | Shallow moat | No price data | |
| 264 | LIFEMD, INC. | LFMD | $173M | 45 | Shallow moat | No price data | |
| 265 | 10x Genomics, Inc. | TXG | $5.9B | 45 | Shallow moat | No price data | |
| 266 | MYRIAD GENETICS, INC. | MYGN | $525M | 45 | Shallow moat | No price data | |
| 267 | Ocular Therapeutix, Inc. | OCUL | $1.8B | 45 | Shallow moat | No price data | |
| 268 | Longeveron Inc. | LGVN | $10.5B | 45 | Shallow moat | No price data | |
| 269 | Neogen Corporation | NEOG | $2.0B | 45 | Shallow moat | No price data | |
| 270 | ANAPTYSBIO, INC. | ANAB | $1.5B | 45 | Shallow moat | No price data | |
| 271 | Crinetics Pharmaceuticals, Inc. | CRNX | $8.0B | 45 | Shallow moat | No price data | |
| 272 | KAYA HOLDINGS, INC. | KAYS | $12439 | 44 | Shallow moat | No price data | |
| 273 | NEUROPACE, INC. | NPCE | $497M | 44 | Shallow moat | No price data | |
| 274 | MKS INC | MKSI | $22.1B | 44 | Shallow moat | 374% above value if growth stopped today | |
| 275 | TELADOC HEALTH, INC. | TDOC | $1.6B | 44 | Shallow moat | No price data | |
| 276 | Exagen Inc. | XGN | $107M | 44 | Shallow moat | No price data | |
| 277 | Pfizer Inc. | PFE | $139.5B | 44 | Shallow moat | 3% above value if growth stopped today | |
| 278 | SONOMA PHARMACEUTICALS, INC. | SNOA | $2.1M | 44 | Shallow moat | No price data | |
| 279 | ARCUTIS BIOTHERAPEUTICS, INC. | ARQT | $3.4B | 44 | Shallow moat | No price data | |
| 280 | THERAVANCE BIOPHARMA, INC. | TBPH | $861M | 44 | Shallow moat | No price data | |
| 281 | SPECTRAL AI, INC. | MDAI | $50.3M | 44 | Shallow moat | No price data | |
| 282 | Ralliant Corporation | RAL | $7.8B | 44 | Shallow moat | 68% above value if growth stopped today | |
| 283 | Tenon Medical, Inc. | TNON | $2.1M | 43 | Shallow moat | No price data | |
| 284 | MANGOCEUTICALS, INC. | MGRX | $48806 | 43 | Shallow moat | No price data | |
| 285 | Stereotaxis, Inc. | STXS | Not reported | 43 | Shallow moat | No price data | |
| 286 | STAAR SURGICAL CO | STAA | $1.2B | 43 | Shallow moat | 387% above value if growth stopped today | |
| 287 | PROCYON CORPORATION | PCYN | $2.1M | 43 | Shallow moat | No price data | |
| 288 | NEURONETICS, INC. | STIM | $119M | 43 | Shallow moat | No price data | |
| 289 | NEXALIN TECHNOLOGY, INC. | NXL | $9.2M | 43 | Shallow moat | No price data | |
| 290 | Fortress Biotech, Inc. | FBIO | $105M | 43 | Shallow moat | No price data | |
| 291 | GUARDANT HEALTH, INC. | GH | $19.2B | 43 | Shallow moat | No price data | |
| 292 | Escalon Medical Corp. | ESMC | $1.5M | 43 | Shallow moat | 101% above value if growth stopped today | |
| 293 | iRhythm Holdings, Inc. | IRTC | $3.5B | 43 | Shallow moat | No price data | |
| 294 | Lifeward Ltd. | LFWD | $10.7M | 43 | Shallow moat | No price data | |
| 295 | QUANTUM-SI INCORPORATED | QSI | $152M | 43 | Shallow moat | No price data | |
| 296 | Scilex Holding Co | SCLX | $48.1M | 43 | Shallow moat | No price data | |
| 297 | CAREDX, INC. | CDNA | $1.9B | 43 | Shallow moat | No price data | |
| 298 | ARDELYX, INC. | ARDX | $1.2B | 43 | Shallow moat | No price data | |
| 299 | Maravai LifeSciences Holdings, Inc. | MRVI | $976M | 43 | Shallow moat | No price data | |
| 300 | Coherus Oncology, Inc. | CHRS | $171M | 43 | Shallow moat | No price data | |
| 301 | Aspira Women’s Health Inc. | AWHL | Not reported | 42 | Shallow moat | No price data | |
| 302 | INSMED INCORPORATED | INSM | $22.9B | 42 | Shallow moat | No price data | |
| 303 | CNBX PHARMACEUTICALS INC. | CNBX | $55396 | 42 | Shallow moat | No price data | |
| 304 | OrthoPediatrics Corp | KIDS | $474M | 42 | Shallow moat | No price data | |
| 305 | Synergy CHC Corp. | SNYR | $1.9M | 42 | Shallow moat | No price data | |
| 306 | Treace Medical Concepts, Inc. | TMCI | Not reported | 42 | Shallow moat | No price data | |
| 307 | Elutia Inc. | ELUT | Not reported | 42 | Shallow moat | No price data | |
| 308 | Nuo Therapeutics, Inc. | AURX | $49.1M | 42 | Shallow moat | No price data | |
| 309 | ASSEMBLY BIOSCIENCES, INC. | ASMB | $405M | 42 | Shallow moat | No price data | |
| 310 | PULMATRIX, INC. | PULM | $6M | 42 | Shallow moat | No price data | |
| 311 | AVANOS MEDICAL, INC. | AVNS | $1.2B | 42 | Shallow moat | No price data | |
| 312 | Decoy Therapeutics Inc. | DCOY | Not reported | 42 | Shallow moat | No price data | |
| 313 | Bolt Biotherapeutics, Inc. | BOLT | $7.4M | 42 | Shallow moat | No price data | |
| 314 | PRAXIS PRECISION MEDICINES, INC. | PRAX | $8.2B | 42 | Shallow moat | No price data | |
| 315 | INMED PHARMACEUTICALS INC. | INM | $3.4M | 42 | Shallow moat | No price data | |
| 316 | Invivyd, Inc. | IVVD | $172M | 42 | Shallow moat | No price data | |
| 317 | Anteris Technologies Global Corp. | AVR | $338M | 42 | Shallow moat | No price data | |
| 318 | CORMEDIX INC. | CRMD | $624M | 42 | Shallow moat | No price data | |
| 319 | Sensus Healthcare, Inc. | SRTS | $49.9M | 42 | Shallow moat | 2% below value if growth stopped today | |
| 320 | Zeo ScientifiX, Inc. | ZEOX | $11.1M | 42 | Shallow moat | No price data | |
| 321 | Establishment Labs Holdings Inc. | ESTA | $2.7B | 42 | Shallow moat | No price data | |
| 322 | Celldex Therapeutics, Inc. | CLDX | $2.3B | 42 | Shallow moat | No price data | |
| 323 | AXOGEN, INC. | AXGN | $1.9B | 42 | Shallow moat | No price data | |
| 324 | CRYO-CELL INTERNATIONAL, INC. | CCEL | $27.9M | 42 | Shallow moat | 524% above value if growth stopped today | |
| 325 | EVOLUS, INC. | EOLS | $389M | 42 | Shallow moat | No price data | |
| 326 | Leef Brands, Inc. | LEEEF | $51.1M | 42 | Shallow moat | No price data | |
| 327 | AGAPE ATP CORPORATION | ATPC | $2.5M | 42 | Shallow moat | No price data | |
| 328 | Vir Biotechnology, Inc. | VIR | $1.2B | 42 | Shallow moat | No price data | |
| 329 | UPSTREAM BIO, INC. | UPB | $348M | 42 | Shallow moat | No price data | |
| 330 | ALLIENT INC | ALNT | $1.5B | 42 | Shallow moat | 350% above value if growth stopped today | |
| 331 | DENTSPLY SIRONA Inc. | XRAY | $2.6B | 42 | Shallow moat | No price data | |
| 332 | AEHR TEST SYSTEMS | AEHR | $2.3B | 42 | Shallow moat | 2072% above value if growth stopped today | |
| 333 | BioAdaptives Inc. | BDPT | $14651 | 42 | Shallow moat | No price data | |
| 334 | Inogen Inc | INGN | $167M | 41 | Shallow moat | No price data | |
| 335 | PACIRA BIOSCIENCES, INC. | PCRX | $1.1B | 41 | Shallow moat | 24% above value if growth stopped today | |
| 336 | Surgery Partners, Inc. | SGRY | $2.0B | 41 | Shallow moat | No price data | |
| 337 | CONCENTRA GROUP HOLDINGS PARENT, INC. | CON | $4.1B | 41 | Shallow moat | 105% above value if growth stopped today | |
| 338 | MACROGENICS, INC. | MGNX | $234M | 41 | Shallow moat | No price data | |
| 339 | TRAVERE THERAPEUTICS, INC. | TVTX | $5.2B | 41 | Shallow moat | No price data | |
| 340 | PetVivo Holdings, Inc. | PETV | $25.8M | 41 | Shallow moat | No price data | |
| 341 | Lineage Cell Therapeutics, Inc. | LCTX | $250M | 41 | Shallow moat | No price data | |
| 342 | LENSAR, Inc. | LNSR | $67.2M | 41 | Shallow moat | No price data | |
| 343 | NATERA, INC. | NTRA | $36.6B | 41 | Shallow moat | No price data | |
| 344 | CERUS CORPORATION | CERS | $563M | 41 | Shallow moat | No price data | |
| 345 | CLEARPOINT NEURO, INC. | CLPT | $415M | 41 | Shallow moat | No price data | |
| 346 | ABEONA THERAPEUTICS INC. | ABEO | $333M | 41 | Shallow moat | No price data | |
| 347 | XENETIC BIOSCIENCES, INC. | XBIO | $6M | 41 | Shallow moat | No price data | |
| 348 | Nuwellis, Inc. | NUWE | $3.5M | 41 | Shallow moat | No price data | |
| 349 | BioLife Solutions, Inc. | BLFS | $1.4B | 41 | Shallow moat | No price data | |
| 350 | PLURI INC. | PLUR | $14.1M | 41 | Shallow moat | No price data | |
| 351 | RAPID MICRO BIOSYSTEMS, INC. | RPID | $88.9M | 41 | Shallow moat | No price data | |
| 352 | Stablecoin Development Corporation | SDEV | $28M | 41 | Shallow moat | No price data | |
| 353 | SUNSHINE BIOPHARMA INC. | SBFM | $8.1M | 41 | Shallow moat | No price data | |
| 354 | GRAIL, Inc. | GRAL | Not reported | 41 | Shallow moat | No price data | |
| 355 | Vivos Therapeutics, Inc. | VVOS | $3.7M | 41 | Shallow moat | No price data | |
| 356 | Biofrontera Inc. | BFRI | $12.7M | 41 | Shallow moat | No price data | |
| 357 | ADAPTIVE BIOTECHNOLOGIES CORPORATION | ADPT | $3.4B | 41 | Shallow moat | No price data | |
| 358 | Fractyl Health, Inc. | GUTS | $119M | 41 | Shallow moat | No price data | |
| 359 | INTEGRA LIFESCIENCES HOLDINGS CORP | IART | $1.5B | 40 | Shallow moat | 105% above value if growth stopped today | |
| 360 | TELA Bio, Inc. | TELA | $30.8M | 40 | Shallow moat | No price data | |
| 361 | Jaguar Health, Inc. | JAGX | Not reported | 40 | Shallow moat | No price data | |
| 362 | GeneDx Holdings Corp. | WGS | $1.7B | 40 | Shallow moat | No price data | |
| 363 | Opus Genetics, Inc. | IRD | $215M | 40 | Shallow moat | No price data | |
| 364 | Seer, Inc. | SEER | Not reported | 40 | Shallow moat | No price data | |
| 365 | BENITEC BIOPHARMA INC. | BNTC | $293M | 40 | Shallow moat | No price data | |
| 366 | EUDA Health Holdings Ltd | EUDA | $22.5M | 40 | Shallow moat | No price data | |
| 367 | Petros Pharmaceuticals, Inc. | PTPI | $169138 | 40 | Shallow moat | No price data | |
| 368 | TRANSCAT, INC. | TRNS | $792M | 40 | Shallow moat | 412% above value if growth stopped today | |
| 369 | ARTIVION, INC. | AORT | $1.2B | 40 | Shallow moat | No price data | |
| 370 | ADM TRONICS UNLIMITED, INC. | ADMT | $2.7M | 40 | Shallow moat | No price data | |
| 371 | Hongchang International Co., Ltd | HCIL | Not reported | 40 | Shallow moat | No price data | |
| 372 | ENDRA Life Sciences Inc. | NDRA | $5.7M | 40 | Shallow moat | No price data | |
| 373 | VIREO GROWTH INC. | VREOF | $7.2B | 40 | Shallow moat | No price data | |
| 374 | Sintx Technologies, Inc. | SINT | $5.6M | 40 | No moat | No price data | |
| 375 | ENvue Medical, Inc. | FEED | $4 | 40 | No moat | No price data | |
| 376 | Clearside Biomedical, Inc. | CLSDQ | $19.1M | 40 | No moat | No price data | |
| 377 | PROCEPT BioRobotics Corporation | PRCT | $940M | 40 | No moat | No price data | |
| 378 | PLUS THERAPEUTICS, INC. | PSTV | $531M | 40 | No moat | No price data | |
| 379 | AngioDynamics, Inc. | ANGO | $567M | 40 | No moat | No price data | |
| 380 | SUTRO BIOPHARMA, INC. | STRO | $196M | 40 | No moat | No price data | |
| 381 | LABCORP HOLDINGS INC. | LH | $24.4B | 39 | No moat | 95% above value if growth stopped today | |
| 382 | Data I/O Corporation | DAIO | $29.3M | 39 | No moat | No price data | |
| 383 | uniQure N.V. | QURE | $2.4B | 39 | No moat | No price data | |
| 384 | CONMED CORPORATION | CNMD | $1.3B | 39 | No moat | 22% above value if growth stopped today | |
| 385 | Pediatrix Medical Group, Inc. | MD | $2.2B | 39 | No moat | 196% above value if growth stopped today | |
| 386 | RADNOSTIX INC. | INIS | $31.7M | 39 | No moat | No price data | |
| 387 | INTERNATIONAL STEM CELL CORPORATION | ISCO | $2.5M | 39 | No moat | No price data | |
| 388 | Avalo Therapeutics, Inc. | AVTX | $341M | 39 | No moat | No price data | |
| 389 | Septerna, Inc. | SEPN | $1.5B | 39 | No moat | No price data | |
| 390 | REFLECT SCIENTIFIC, INC. | RSCF | $3.4M | 39 | No moat | 245% above value if growth stopped today | |
| 391 | Lyra Therapeutics, Inc. | LYRA | $922939 | 39 | No moat | No price data | |
| 392 | ENDONOVO THERAPEUTICS, INC. | ENDV | $21323 | 39 | No moat | No price data | |
| 393 | Jazz Pharmaceuticals plc | JAZZ | $15.6B | 39 | No moat | No price data | |
| 394 | NEKTAR THERAPEUTICS | NKTR | $1.4B | 39 | No moat | No price data | |
| 395 | INTEGER HOLDINGS CORPORATION | ITGR | $3.4B | 39 | No moat | 144% above value if growth stopped today | |
| 396 | ORAMED PHARMACEUTICALS INC. | ORMP | $158M | 39 | No moat | No price data | |
| 397 | GLAUKOS Corp | GKOS | $8.8B | 39 | No moat | No price data | |
| 398 | QUANTERIX CORPORATION | QTRX | $172M | 39 | No moat | No price data | |
| 399 | VYNE THERAPEUTICS INC. | VYNE | $17M | 39 | No moat | No price data | |
| 400 | LIQUIDIA CORPORATION | LQDA | $7.5B | 39 | No moat | No price data | |
| 401 | MARKER THERAPEUTICS, INC. | MRKR | $20.4M | 39 | No moat | No price data | |
| 402 | Tandem Diabetes Care, Inc. | TNDM | $1.2B | 39 | No moat | No price data | |
| 403 | enVVeno Medical Corporation | NVNO | $6.8M | 39 | No moat | No price data | |
| 404 | Tango Therapeutics, Inc. | TNGX | $3.6B | 39 | No moat | No price data | |
| 405 | IONIS PHARMACEUTICALS, INC. | IONS | $9.2B | 38 | No moat | No price data | |
| 406 | HERON THERAPEUTICS, INC. /DE/ | HRTX | $85.8M | 38 | No moat | No price data | |
| 407 | OPTION CARE HEALTH, INC. | OPCH | $3.4B | 38 | No moat | 31% above value if growth stopped today | |
| 408 | INVO Fertility, Inc. | IVF | $477366 | 38 | No moat | No price data | |
| 409 | Silo Pharma, Inc. | SILO | $59.5M | 38 | No moat | No price data | |
| 410 | Serina Therapeutics, Inc. | SER | $22.3M | 38 | No moat | No price data | |
| 411 | Milestone Scientific Inc. | MLSS | $31.4M | 38 | No moat | No price data | |
| 412 | Insight Molecular Diagnostics Inc. | IMDX | $136M | 38 | No moat | No price data | |
| 413 | CG Oncology, Inc. | CGON | $5.6B | 38 | No moat | No price data | |
| 414 | Pyxis Oncology, Inc. | PYXS | $164M | 38 | No moat | No price data | |
| 415 | OMEROS CORPORATION | OMER | $702M | 38 | No moat | No price data | |
| 416 | Creative Medical Technology Holdings, Inc. | CELZ | $3M | 38 | No moat | No price data | |
| 417 | BECTON DICKINSON & CO | BDX | $44.6B | 38 | No moat | 28% above value if growth stopped today | |
| 418 | HeartSciences Inc. | HSCS | $7.6M | 38 | No moat | No price data | |
| 419 | AVITA MEDICAL, INC. | RCEL | $141M | 38 | No moat | No price data | |
| 420 | Kestra Medical Technologies, Ltd. | KMTS | $1.2B | 38 | No moat | No price data | |
| 421 | SCIENTIFIC INDUSTRIES, INC. | SCND | $6.9M | 38 | No moat | No price data | |
| 422 | PRECIPIO, INC. | PRPO | $42.2M | 37 | No moat | No price data | |
| 423 | BioXcel Therapeutics, Inc. | BTAI | $18.9M | 37 | No moat | No price data | |
| 424 | APYX MEDICAL CORPORATION | APYX | $164M | 37 | No moat | No price data | |
| 425 | Polomar Health Services, Inc. | PMHS | $2.2M | 37 | No moat | No price data | |
| 426 | PRELUDE THERAPEUTICS INC | PRLD | $241M | 37 | No moat | No price data | |
| 427 | SCHOLAR ROCK HOLDING CORP | SRRK | $5.2B | 37 | No moat | No price data | |
| 428 | RALLYBIO CORPORATION | RLYB | $86.2M | 37 | No moat | No price data | |
| 429 | EQUILLIUM, INC. | EQ | $153M | 37 | No moat | No price data | |
| 430 | Nuvation Bio Inc. | NUVB | $2.2B | 37 | No moat | No price data | |
| 431 | Monte Rosa Therapeutics, Inc. | GLUE | $1.5B | 37 | No moat | No price data | |
| 432 | Prime Medicine, Inc. | PRME | $533M | 37 | No moat | No price data | |
| 433 | Summit Therapeutics Inc. | SMMT | $10.6B | 37 | No moat | No price data | |
| 434 | VERU INC. | VERU | $33M | 37 | No moat | No price data | |
| 435 | InnovAge Holding Corp. | INNV | $1.6B | 37 | No moat | No price data | |
| 436 | NATURAL ALTERNATIVES INTERNATIONAL INC | NAII | $14.8M | 37 | No moat | 47% below value if growth stopped today | |
| 437 | MannKind Corporation | MNKD | $1.3B | 37 | No moat | No price data | |
| 438 | NovoCure Limited | NVCR | $2.0B | 37 | No moat | No price data | |
| 439 | GUIDED THERAPEUTICS, INC. | GTHP | $22.4M | 37 | No moat | No price data | |
| 440 | Journey Medical Corp | DERM | $152M | 37 | No moat | No price data | |
| 441 | ORASURE TECHNOLOGIES, INC | OSUR | $279M | 36 | No moat | No price data | |
| 442 | NeuroOne Medical Technologies Corporation | NMTC | $95M | 36 | No moat | No price data | |
| 443 | XBIOTECH INC. | XBIT | $69.2M | 36 | No moat | No price data | |
| 444 | REVVITY, INC | RVTY | $12.4B | 36 | No moat | 23% above value if growth stopped today | |
| 445 | Silence Therapeutics plc | SLN | $1.6B | 36 | No moat | No price data | |
| 446 | ZYMEWORKS INC. | ZYME | $1.7B | 36 | No moat | No price data | |
| 447 | EMERGENT BIOSOLUTIONS INC. | EBS | $378M | 36 | No moat | No price data | |
| 448 | TherapeuticsMD, Inc. | TXMD | $23.8M | 36 | No moat | No price data | |
| 449 | MARIMED INC. | MRMD | $26.2M | 36 | No moat | No price data | |
| 450 | Aclaris Therapeutics, Inc. | ACRS | $630M | 36 | No moat | No price data | |
| 451 | ADAPTIMMUNE THERAPEUTICS PLC | ADAPY | $44.5M | 36 | No moat | No price data | |
| 452 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | $2.1B | 36 | No moat | No price data | |
| 453 | InspireMD, Inc. | NSPR | $29.8M | 36 | No moat | 99% below value if growth stopped today | |
| 454 | MOVING iMAGE TECHNOLOGIES INC. | MITQ | $5.1M | 36 | No moat | No price data | |
| 455 | PROTAGONIST THERAPEUTICS, INC. | PTGX | $8.5B | 36 | No moat | No price data | |
| 456 | Century Therapeutics, Inc. | IPSC | $185M | 36 | No moat | No price data | |
| 457 | VIVOSIM LABS, INC. | VIVS | $1.2M | 36 | No moat | No price data | |
| 458 | Twist Bioscience Corporation | TWST | $5.5B | 36 | No moat | No price data | |
| 459 | Atara Biotherapeutics, Inc. | ATRA | $57.9M | 36 | No moat | No price data | |
| 460 | Organon & Co. | OGN | $3.5B | 36 | No moat | 67% below value if growth stopped today | |
| 461 | WELSIS CORP. | WLSS | $1.7M | 35 | No moat | No price data | |
| 462 | INTEGRATED BIOPHARMA INC | INBP | $5M | 35 | No moat | 52% below value if growth stopped today | |
| 463 | EDAP TMS SA | FOCL | $226M | 35 | No moat | No price data | |
| 464 | PERSPECTIVE THERAPEUTICS, INC. | CATX | $216M | 35 | No moat | No price data | |
| 465 | AGENUS INC | AGEN | $211M | 35 | No moat | No price data | |
| 466 | CYTOSORBENTS CORPORATION | CTSO | $22.6M | 35 | No moat | No price data | |
| 467 | TSCAN THERAPEUTICS, INC. | TCRX | Not reported | 35 | No moat | No price data | |
| 468 | STANDARD BIOTOOLS INC. | LAB | $322M | 35 | No moat | No price data | |
| 469 | Harrow, Inc. | HROW | $1.4B | 35 | No moat | No price data | |
| 470 | Quantum Cyber N.V. | QUCY | $10.6M | 35 | No moat | No price data | |
| 471 | Moderna, Inc. | MRNA | $21.3B | 35 | No moat | No price data | |
| 472 | Denali Therapeutics Inc. | DNLI | $3.6B | 35 | No moat | No price data | |
| 473 | Beam Therapeutics Inc. | BEAM | $2.6B | 35 | No moat | No price data | |
| 474 | agilon health, inc. | AGL | $40.6B | 35 | No moat | No price data | |
| 475 | Coya Therapeutics, Inc. | COYA | $89M | 35 | No moat | No price data | |
| 476 | GEOSPACE TECHNOLOGIES CORP | GEOS | $90.8M | 35 | No moat | 131% above value if growth stopped today | |
| 477 | STREAMEX CORP. | STEX | $36.7M | 35 | No moat | No price data | |
| 478 | Vistagen Therapeutics, Inc. | VTGN | $9.3M | 34 | No moat | No price data | |
| 479 | Onconetix, Inc. | ONCO | $1.3M | 34 | No moat | No price data | |
| 480 | CO-DIAGNOSTICS, INC. | CODX | $63 | 34 | No moat | No price data | |
| 481 | Intelligent Bio Solutions Inc. | INBS | $12.8M | 34 | No moat | No price data | |
| 482 | Immuneering Corporation | IMRX | $190M | 34 | No moat | No price data | |
| 483 | BESPOKE EXTRACTS, INC. | BSPK | $7807 | 34 | No moat | No price data | |
| 484 | BIODESIX INC | BDSX | $182M | 34 | No moat | No price data | |
| 485 | Lakeland Industries, Inc. | LAKE | $106M | 34 | No moat | 407% above value if growth stopped today | |
| 486 | AXSOME THERAPEUTICS, INC. | AXSM | $12.3B | 34 | No moat | No price data | |
| 487 | RxSight, Inc. | RXST | $214M | 34 | No moat | No price data | |
| 488 | ABVC BioPharma, Inc. | ABVC | $28.8M | 34 | No moat | No price data | |
| 489 | Tonix Pharmaceuticals Holding Corp. | TNXP | $5.5B | 34 | No moat | No price data | |
| 490 | Nexentis Technologies Inc. | NXTS | $5M | 34 | No moat | No price data | |
| 491 | Skinvisible, Inc. | SKVI | $1.1M | 34 | No moat | No price data | |
| 492 | Bionano Genomics, Inc. | BNGO | $11.9M | 34 | No moat | No price data | |
| 493 | Verastem, Inc. | VSTM | $470M | 34 | No moat | No price data | |
| 494 | HYPERION DEFI, INC. | HYPD | $21.8M | 34 | No moat | No price data | |
| 495 | ARVINAS, INC. | ARVN | $510M | 34 | No moat | No price data | |
| 496 | Relay Therapeutics, Inc. | RLAY | $3.2B | 34 | No moat | No price data | |
| 497 | KYNTRA BIO, INC. | KYNB | $28.5M | 33 | No moat | No price data | |
| 498 | STRATA CRITICAL MEDICAL, INC. | SRTA | $438M | 33 | No moat | No price data | |
| 499 | DBV TECHNOLOGIES S.A. | DBVT | Not reported | 33 | No moat | No price data | |
| 500 | ImmuCell Corporation | ICCC | $99.8M | 33 | No moat | No price data |